These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 9412310

  • 1. Unrelated donor bone marrow transplantation for chronic myelogenous leukemia: a decision analysis.
    Lee SJ, Kuntz KM, Horowitz MM, McGlave PB, Goldman JM, Sobocinski KA, Hegland J, Kollman C, Parsons SK, Weinstein MC, Weeks JC, Antin JH.
    Ann Intern Med; 1997 Dec 15; 127(12):1080-8. PubMed ID: 9412310
    [Abstract] [Full Text] [Related]

  • 2. Bone marrow transplantation for chronic myelogenous leukemia: clinical outcomes.
    Enright H, Davies S, McGlave P.
    Clin Transpl; 1994 Dec 15; ():283-93. PubMed ID: 7547549
    [Abstract] [Full Text] [Related]

  • 3. Cost-effectiveness of interferon-alpha and conventional chemotherapy in chronic myelogenous leukemia.
    Kattan MW, Inoue Y, Giles FJ, Talpaz M, Ozer H, Guilhot F, Zuffa E, Huber SL, Beck JR.
    Ann Intern Med; 1996 Oct 01; 125(7):541-8. PubMed ID: 8815752
    [Abstract] [Full Text] [Related]

  • 4. Systematic assessment of decision-analytic models for chronic myeloid leukemia.
    Rochau U, Schwarzer R, Jahn B, Sroczynski G, Kluibenschaedl M, Wolf D, Radich J, Brixner D, Gastl G, Siebert U.
    Appl Health Econ Health Policy; 2014 Apr 01; 12(2):103-15. PubMed ID: 24385259
    [Abstract] [Full Text] [Related]

  • 5. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
    Ohnishi K, Minami S, Ueda T, Nishimura M, Tsubaki K, Takemoto Y, Takeshita A, Sao H, Kageyama S, Ueda R, Ohno R.
    Int J Hematol; 2000 Aug 01; 72(2):229-36. PubMed ID: 11039674
    [Abstract] [Full Text] [Related]

  • 6. Treatment of CML with unrelated donor marrow transplant.
    McGlave P.
    Leuk Lymphoma; 1993 Aug 01; 11 Suppl 1():209-11. PubMed ID: 8251898
    [Abstract] [Full Text] [Related]

  • 7. Cost-efficacy of imatinib versus allogeneic bone marrow transplantation with a matched unrelated donor in the treatment of chronic myelogenous leukemia: a decision-analytic approach.
    Skrepnek GH, Ballard EE.
    Pharmacotherapy; 2005 Mar 01; 25(3):325-34. PubMed ID: 15843279
    [Abstract] [Full Text] [Related]

  • 8. Chronic myelogenous leukemia. Curable with early diagnosis and treatment.
    Hill JM, Meehan KR.
    Postgrad Med; 1999 Sep 01; 106(3):149-52, 157-9. PubMed ID: 10494272
    [Abstract] [Full Text] [Related]

  • 9. Successful unrelated marrow transplantation for patients over the age of 40 with chronic myelogenous leukemia.
    Drobyski WR, Pelz C, Kabler-Babbitt C, Hessner M, Baxter-Lowe LA, Keever-Taylor CA.
    Biol Blood Marrow Transplant; 1998 Sep 01; 4(1):3-12. PubMed ID: 9701386
    [Abstract] [Full Text] [Related]

  • 10. Cytarabine added to interferon improves the cost-effectiveness of initial therapy for patients with early chronic phase chronic myelogenous leukemia.
    Beck JR, Guilhot J, Giles FJ, Aoki N, Wirt DP, Guilhot F.
    Leuk Lymphoma; 2001 Mar 01; 41(1-2):117-24. PubMed ID: 11342363
    [Abstract] [Full Text] [Related]

  • 11. Early allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era: a preliminary assessment.
    Simon W, Segel GB, Lichtman MA.
    Blood Cells Mol Dis; 2006 Mar 01; 37(2):116-24; discussion 125-7. PubMed ID: 16904348
    [Abstract] [Full Text] [Related]

  • 12. Absence of influence of prior treatment with interferon on the outcome of allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Tomás JF, López-Lorenzo JL, Requena MJ, Aguilar R, Steegmann JL, Cámara R, Alegre A, Arranz R, Figuera A, Fernández-Rañada JM.
    Bone Marrow Transplant; 1998 Jul 01; 22(1):47-51. PubMed ID: 9678795
    [Abstract] [Full Text] [Related]

  • 13. Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phase.
    Gale RP, Park RE, Dubois RW, Herzig GP, Hocking WG, Horowitz MM, Keating A, Kempin S, Linker CA, Schiffer CA, Wiernik PH, Weisdorf DJ, Rai KR.
    Leuk Res; 1999 Sep 01; 23(9):817-26. PubMed ID: 10475621
    [Abstract] [Full Text] [Related]

  • 14. Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation.
    Gratwohl A, Hermans J, Niederwieser D, Frassoni F, Arcese W, Gahrton G, Bandini G, Carreras E, Vernant JP, Bosi A.
    Bone Marrow Transplant; 1993 Nov 01; 12(5):509-16. PubMed ID: 8298562
    [Abstract] [Full Text] [Related]

  • 15. The costs and cost-effectiveness of unrelated donor bone marrow transplantation for chronic phase chronic myelogenous leukemia.
    Lee SJ, Anasetti C, Kuntz KM, Patten J, Antin JH, Weeks JC.
    Blood; 1998 Dec 01; 92(11):4047-52. PubMed ID: 9834208
    [Abstract] [Full Text] [Related]

  • 16. Chemotherapy and bone marrow transplantation in the treatment of chronic myelogenous leukemia.
    Kantarjian HM, Talpaz M.
    Semin Oncol; 1994 Dec 01; 21(6 Suppl 14):8-13. PubMed ID: 7992099
    [Abstract] [Full Text] [Related]

  • 17. Effects of age on prognosis with imatinib mesylate therapy for patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
    Cortes J, Talpaz M, O'Brien S, Giles F, Beth Rios M, Shan J, Faderl S, Garcia-Manero G, Ferrajoli A, Wierda W, Kantarjian H.
    Cancer; 2003 Sep 15; 98(6):1105-13. PubMed ID: 12973833
    [Abstract] [Full Text] [Related]

  • 18. Upper and lower time limits in the decision to recommend marrow transplantation for patients with chronic myelogenous leukaemia.
    Simon W, Segel GB, Lichtman MA.
    Br J Haematol; 1988 Sep 15; 70(1):31-6. PubMed ID: 3052568
    [Abstract] [Full Text] [Related]

  • 19. Biology and treatment of chronic myelogenous leukemia.
    Giles FJ, Kantarjian HM.
    Oncology (Williston Park); 1997 Sep 15; 11(9):1295-300; discussion 1302-10. PubMed ID: 9306419
    [Abstract] [Full Text] [Related]

  • 20. Related donor marrow transplant for chronic myeloid leukemia: patient characteristics predictive of outcome.
    Enright H, Daniels K, Arthur DC, Dusenbery KE, Kersey JH, Kim T, Miller WJ, Ramsay NK, Vercellotti GM, Weisdorf DJ, McGlave PB.
    Bone Marrow Transplant; 1996 Apr 15; 17(4):537-42. PubMed ID: 8722351
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.